Max Healthcare Institute Limited (NSE:MAXHEALTH)
India
· Delayed Price · Currency is INR | Market Cap | 1.15T |
| Revenue (ttm) | 70.28B |
| Net Income (ttm) | 10.76B |
| Shares Out | n/a |
| EPS (ttm) | 11.01 |
| PE Ratio | 106.79 |
| Forward PE | 61.48 |
| Dividend | 1.50 (0.13%) |
| Ex-Dividend Date | Aug 23, 2024 |
| Volume | 1,799,509 |
| Average Volume | 1,688,314 |
| Open | 1,229.80 |
| Previous Close | 1,226.80 |
| Day's Range | 1,179.60 - 1,229.90 |
| 52-Week Range | 836.60 - 1,256.20 |
| Beta | 0.26 |
| RSI | 51.87 |
| Earnings Date | May 28, 2025 |
About Max Healthcare Institute
Max Healthcare Institute Limited provides medical and healthcare services in India. It offers services in various specialties, including advanced cardiac care, orthopaedics, oncology, renal sciences, neurosciences, minimal access metabolic and bariatric surgery, obstetrics, gynaecology, paediatrics, nephrology, and general surgery, as well as liver, heart, kidney, lung and bone marrow transplants. The company also provides Max@Home, a platform that offers health and wellness services at home; and MaxLab, which provides diagnostic services to pa... [Read more]
Financial Performance
In 2024, Max Healthcare Institute's revenue was 70.28 billion, an increase of 30.01% compared to the previous year's 54.06 billion. Earnings were 10.76 billion, an increase of 1.72%.
Financial StatementsNews
Stocks hitting 52-week highs today, June 16: Bharat Electronics, Laurus Labs, Max Healthcare, JK Cement and more
Indian equity markets closed on a positive note on June 16, 2025, as benchmark indices posted strong gains across the board. The BSE Sensex surged 677.55 points (0.84%) to close at 81,796.15, while th...
Max Healthcare shares jump 2% after Jefferies maintains ‘Buy’ call with target price of Rs 1,400
Max Healthcare shares rose 2% in morning trade after global brokerage Jefferies reiterated its “Buy” rating on the stock with a target price of ₹1,400. The positive sentiment stems from Max Healthcare...
Stocks to watch on June 12: Tata Comm, Max Health, Dr Reddy’s, HDFC Life, PayTM in focus on brokerage views
Several brokerages have released their latest views and price targets on key listed companies. Here are the highlights of fund house recommendations for the day: CLSA on Tata Communications: Maintain ...
Jefferies maintains ‘Buy’ call on Max Healthcare; sees 75% bed capacity expansion as key growth driver
Jefferies has reiterated a Buy rating on Max Healthcare Institute, assigning a target price of ₹1,400, citing strong expansion plans and a proven execution record. The company is set to expand its tot...
Brokerages on Max Healthcare stock: Buy, sell or hold? Check UBS, HSBC calls
Max Healthcare is in focus following its Q4 FY25 results, with brokerages offering mixed views on the stock. While UBS turned more bullish, raising its target price to Rs 1,350 and reiterating a buy c...
HSBC maintains ‘Hold’ on Max Healthcare; sees 7.8% downside amid limited re-rating scope
HSBC has maintained a ‘Hold’ rating on Max Healthcare Institute Ltd, assigning a target price of ₹1,055, which implies a 7.8% downside from the current market price of ₹1,144 (as of latest close). The...
UBS maintains ‘Buy’ on Max Healthcare, raises target price; sees 18% upside amid expansion-led growth
UBS has maintained its ‘Buy’ rating on Max Healthcare Institute Ltd, while raising the target price to ₹1,350, implying an upside of 18% from the current market price of ₹1,144.00 (as of latest close)...
Stocks to watch on news today: Dr Reddy’s, Sun Pharma, BEL, JSW Steel, NBCC, Max Healthcare, PNC Infra in focus
Several companies are likely to remain in focus today owing to key regulatory updates, project wins, acquisitions, and strategic corporate announcements. Dr Reddy’s Laboratories received two observati...
Pharma and healthcare stocks: Macquarie turns bullish on Sun Pharma, Cipla, Lupin; bearish on Apollo Hospitals, Max Healthcare
Macquarie believes the recent correction in pharmaceutical formulation stocks triggered by tariff-related concerns presents a compelling buying opportunity. In its latest sector note, the brokerage ha...
Max Healthcare unit merger aims at improved cash flow and reduced compliance burden
Crosslay Remedies to merge into Jaypee Healthcare as part of Max Healthcare restructuring.
Max Healthcare to enter long-term service agreement for New Delhi Hospital
Max Healthcare Institute Limited has announced its board’s approval to enter into a Long-term Service Agreement (LTSA) with Bharat Prakritik Chikitsa Mission (BPCM) for a 200-bedded hospital in Pitamp...
Top stocks to buy: Stock recommendations for the week starting March 3
Stock market recommendations: Motilal Oswal Financial Services Ltd recommends HDFC Bank and Max Healthcare for this week. HDFC Bank is set to benefit from RBI's new policies Max Healthcare shows signi...
Max Healthcare shares surge 2% as UBS upgrades to ‘Buy’ rating with target price of Rs 1,200
Max Healthcare shares jumped 2% after UBS upgraded the stock to ‘Buy’ from ‘Neutral’ and raised its target price to ₹1,200. As of 9:39 AM, the shares were trading 1.63% higher at Rs 1,031.20. The brok...
UBS upgrades Max Healthcare to ‘Buy’, raises target to ₹1,200 on strong expansion visibility
UBS has upgraded Max Healthcare to Buy from Neutral and raised its target price to ₹1,200, citing strong visibility on bed additions and faster break-even of new hospitals. The brokerage believes the ...
Q3 2025 Max Healthcare Institute Ltd Earnings Call Transcript
Q3 2025 Max Healthcare Institute Ltd Earnings Call Transcript
Max Healthcare shares in focus: HSBC maintains Hold, sees limited downside post Q3 operational beat
Max Healthcare shares are in focus following a solid Q3FY25 performance, though HSBC has maintained a Hold rating, signaling cautious optimism despite operational improvements. The stock is currently ...
Max Healthcare Q3 FY25 Results: Revenue surges 40% YoY to Rs 1,868 crore, Net Profit down 17.6% YoY
Max Healthcare Institute Limited reported strong Q3 FY25 financial results, showcasing significant growth in revenue and profitability. The company’s revenue from operations increased to Rs 1,868 cror...
Top Q3 FY25 Results Today on January 30, 2025: Adani Enterprises, Adani Ports, Bajaj Finserv, BEL, Biocon, Dabur, Prestige Estates
A host of prominent companies, including Adani Enterprises, Adani Ports, Astral, Bajaj Finserv, Bank of Baroda, BEL, Biocon, Coromandel International, Dabur, Max Healthcare, Navin Fluorine, and Presti...
Stock Market Update, January 8: Anant Raj, PTC Industries, Max Healthcare, Apar Industries and more hit 52-week highs today
The Indian equity markets faced a day of high volatility on January 8, with the BSE Sensex and Nifty 50 indices ending in the red. The BSE Sensex experienced a minor decline of 50.62 points (0.06%), s...
Stock Market Update: Muthoot Finance, Infosys, Max Healthcare and more hit 52-week highs today on December 12, 2024
Indian equity markets faced a challenging trading day on December 12, 2024, with both the Sensex and Nifty indices closing in the red. The Sensex slipped by 236.18 points, or 0.29%, ending the session...
Max Healthcare shares jumpe nearly 3% after Axis Capital initiates “Buy” rating
Max Healthcare shares surged nearly 3% after Axis Capital initiated coverage with a BUY rating and a target price of Rs 1,315. As per Axis Capital, Max Healthcare operates over 2,900 beds and dominate...
Max Healthcare Institute: Stock closes 16.69% below 52-week high, 70.50% above 52-week low
Max Healthcare Institute (NSE: MAXHEALTH) ended trading on November 17, 2024, at ₹1,006.25, reflecting a slight gain of 0.43%. The stock remains 16.69% below its 52-week high of ₹1,207.50 and 70.50% a...
Max Healthcare shares surge 2% after acquisition of Jaypee Healthcare for Rs 227 crore
Max Healthcare’s stock rose 2% in morning trade following the completion of its acquisition of Jaypee Healthcare Limited (JHL). On November 11, 2024, Max Healthcare finalized the purchase of JHL’s rem...
Max Healthcare completes 100% acquisition of Jaypee Healthcare for Rs 227 crore
In a significant development, Max Healthcare has announced the completion of its acquisition of Jaypee Healthcare Limited (JHL), achieving full ownership of the healthcare entity. This acquisition, wh...
Max Healthcare shares rise nearly 3%, emerge as top gainer in morning trade
Max Healthcare Institute shares rise nearly 3%, emerging as one of the top gainers this morning. The stock opened at ₹1,028 and reached an intraday high of ₹1,049.80 on the NSE, showing a 2.47% increa...